Form 8-K · Current report
Ralph Lauren Corporation 8-K, filed Aug 3, 2026
- Filed
- CIK
- 0001037038
- Accession no.
- 0000950142-26-002236
Summary
Ralph Lauren Corporation stockholders elected all of the company's director nominees at the annual meeting held July 30, 2026, ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending April 3, 2027, and approved the compensation of named executive officers on an advisory basis. Each Class B director nominee received 218,812,760 votes for and none withheld; Class A director Darren Walker drew the most opposition with 10,438,404 votes withheld.
Key points
- The annual meeting of stockholders was held on July 30, 2026.
- All director nominees were elected to serve until the 2027 annual meeting.
- Ernst & Young LLP was ratified as independent registered public accounting firm for the fiscal year ending April 3, 2027, with 250,956,322 votes for and 522,890 against.
- Executive compensation was approved on an advisory basis with 247,311,631 votes for and 1,827,343 against.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.07Submission of Matters to a Vote of Security Holders
From the filing
ITEM 5.07. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS. (a) The Annual Meeting of Stockholders of Ralph Lauren Corporation (the “Company”) was held on July 30, 2026. (b) The stockholders (i) elected all of the Company’s nominees for director to serve until the Company’s 2027 Annual Meeting of Stockholders; (ii) ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending April 3, 2027; and (iii) approved, on an advisory basis, the compensation of the Company’s named executive officers and the Company’s compensation philosophy, policies and practices. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.